NCT05418192

Brief Summary

This study focuses on how enriched environment along with the traditional physical therapy improves the gross motor function in spastic quadriplegic cerebral palsy children. And how much dosing is required to gain that clinically significant improvement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 8, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 14, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

January 17, 2023

Status Verified

January 1, 2023

Enrollment Period

9 months

First QC Date

June 8, 2022

Last Update Submit

January 13, 2023

Conditions

Keywords

Therapeutic DosingEnriched Environment

Outcome Measures

Primary Outcomes (1)

  • Gross Motor Function

    To check the improvement in gross motor function on Gross Motor Functional Measure scale of spastic quadriplegic cerebral palsy children. The scoring system of this scale is divided into five dimensions of gross motor function:(a) lying and rolling, (b) sitting, (c) crawling and kneeling, (d) standing, and (e) walking, running and jumping. The scoring is done on four points: 0=does not initiate 1. = initiates 2. = partially completes 3. = completes Higher scores mean better outcome whereas low scores show little to no improvement in gross motor function.

    5 months

Secondary Outcomes (1)

  • Spasticity

    5 months

Study Arms (2)

Group A

EXPERIMENTAL

Intervention Given: Enriched Environment (age-appropriate) + NDT + Therapeutic Dosing

Other: Enriched Environment

Group B

OTHER

Traditional Physical Therapy consisting of NDT

Other: Traditional Physcial Therapy

Interventions

Enriched Environment (EE) consisted of motor and sensory enriched play environment to promote participant's self-generated movements, exploration and task success. EE also included positioning in a graded manner. Visual stimulus and level appropriate vestibular stimulus was also given. Dosing of positioning and sensory inputs was done throughout the therapy. Primary Intervention will be given for 20 to 25 minutes intermittently for period of 4-5 hours a day, 5 days a week for 24 weeks.

Group A

Participants of this group received traditional physical therapy based NDT. No additional dosing guidance was given to this group. No home program was specifically assigned to this group. No specific environmental modifications were made for this group.

Group B

Eligibility Criteria

Age7 Months - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age Group between 7 months to 5 years.
  • Spastic Quadriplegia
  • Gross Motor Function Classification System (GMFCS) level IV and V
  • Modified Ashworth Scale (MAS): level 2
  • Both Gender

You may not qualify if:

  • History of fits
  • Medications
  • Dislocation and fracture
  • Visual/Auditory Impairment
  • Patients taking therapy from multiple places

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Lahore Teaching Hospital

Lahore, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Safa Saleem, DPT

    University of Lahore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2022

First Posted

June 14, 2022

Study Start

January 3, 2022

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

January 17, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations